Reuters logo
3 years ago
BRIEF-Abcam, Cell Marque sign marketing agreement for IVD IHC RabMab antibodies
September 4, 2014 / 11:42 AM / 3 years ago

BRIEF-Abcam, Cell Marque sign marketing agreement for IVD IHC RabMab antibodies

Sept 4 (Reuters) - Abcam Plc

* Abcam and cell marque sign global strategic marketing agreement for ivd ihc rabmab antibodies

* Have signed a global 10-year strategic marketing agreement for abcam`s in vitro diagnostic (ivd) immunohistochemistry (ihc) rabmab primary antibody portfolio.

* Cell marque will apply its extensive ivd expertise to incorporate abcam`s ivd ihc rabmab primary antibodies into its portfolio Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below